Agmatine attenuates neuropathic pain in rats: Possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum

Life Sciences

Volumn 73, Issue 4, 2003, Pages 413-428

  Önal, Aytül ^a   Delen, Yasemin ^a   Ülker, Sibel ^a   Soykan, Necdet ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Agmatine; Neuropathic pain; Nitric oxide; Noradrenergic activity; Norepinephrine

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; AGMATINE; NITRATE; NITRIC OXIDE; NORADRENALIN;

ANIMAL MODEL; ARTICLE; ATTENUATION; BIOCHEMISTRY; BRAIN CORTEX; BRAIN STEM; CONTROLLED STUDY; DRUG MEGADOSE; LIGATION; MALE; NEUROPATHIC PAIN; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENERGIC SYSTEM; PAIN THRESHOLD; RAT; REDUCTION; SCIATIC NERVE;

EID: 0037959800     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00297-2     Document Type: Article

References (75)

1. Auguet M., Viossat I., Marin J.G., Chabrier P.E. Selective inhibition of inducible nitric oxide synthase by agmatine. Japanese Journal of Pharmacology. 69:1995;285-287.
2. Bennett A.D., Everhart A.W., Hulsebasch C.E. Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury. Brain Res. 859:2000;72-82.
3. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in the rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
4. Bennett G.J. An animal model of neuropathic pain: A review. Muscle & Nerve. 16:1993;1040-1048.
5. Bloom F.E. Neurotransmission and the Central Nervous System. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. Goodman and Gilman's The Pharmacological Basis of Therapeutics. ninth ed. 1996;267-293 McGraw-Hill, USA.
6. Bredt D.S., Hwang P.M., Synder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
7. Byas-Smith M.G., Max M.B., Muir J., Kingman A. Transdermal clonidine compared to placebo on painful diabetic neuropathy using a two-stage "enriched enrollment" design. Pain. 60:1995;267-274.
8. Cox T.T., Boeker E.A. Analysis of enzyme kinetics by using integrated rate equations. Arginine decarboxylase. The Biochemical Journal. 245:1987;59-65.
9. Cull-Candy S.G., Brickley S.G., Misra C., Feldmeyer D., Momiyama A., Farrant M. NMDA receptor diversity in the cerebellum: identification of subunits contributing to functional receptors. Neuropharmacology. 37:1998;1369-1380.
10. Davar G., Hama A., Deykin A., Vos B., Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Research. 553:1991;327-330.
11. Do K.Q., Binns K.E., Salt T.E. Release of the nitric oxide precursor, arginine, from the thalamus upon sensory afferent stimulation, ana its effect on thalamic neurons in vivo. Neuroscience. 60:1994;581-586.
12. Egberongbe Y.I., Gentleman S.M., Fakla I.P., Bogerts B., Polak J.M., Roberts G.W. The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience. 59:1994;561-578.
13. Eisenberg E., Pud D. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine? Pain. 74:1998;337-339.
14. Fairbanks C.A., Schreiber K.L., Brewer K.L., Yu C.G., Stone L.S., Kitto K.F., Nguyen H.O., Grocholski B.M., Shoeman D.W., Kehl L.J., Regunathan S., Reis D.J., Yezierski R.P., Wilcox G.L. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proceedings of National Academy of Science USA (abst.). 97:2000;10584-10589.
15. Feng Y., Piletz J.E., Leblanc M.H. Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res. 52:2002;606-611.
16. Galea E., Regunathan S., Eliopoulos U., Feinstein D.L., Reis D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. The Biochemical Journal. 316:1996;247-249.
17. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385.
18. Goldstein R.S., Raber P., Gourin-Lippmann R., Devor M. Contrasting time course of catecholamine accumulation and of spontaneous discharge in experimental neuromas in the rat. Neuroscience Letters. 94:1988;58-63.
19. Gordh T., Sharma H.S., Alm P., Westman J. Spinal nerve lesion induces upregulation of neuronal nitric oxide synthase in the spinal cord. An immunohistochemical investigation in the rat. Amino Acids. 14:1998;105-112.
20. Habu H., Yokoi I., Kabuto H., Mori A. Application of automated flow injection analysis to determine nitrite and nitrate in mouse brain. NeuroReport. 5:1994;1571-1573.
21. Haley J.E., Dickensen A.H., Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuroscience. 31:1992;251-258.
22. 2-adrenoceptors in the brain. European Journal of Pharmacology. 170:1989;19-28.
23. Hoffman B.B., Lefkowitz R.J. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. Goodman and Gilman's The Pharmacological Basis of Therapeutics. ninth ed. 1996;199-248 McGraw-Hill, USA.
24. Horvath G., Kekesi G., Dobos I., Szikszay M., Klimscha W., Benedek G. Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats. European Journal of Pharmacology. 368:1999;197-204.
25. Katz N., Ferrante F.M. Nociception. Ferrante F.M., VadeBoncouer T.R. Postoperative Pain Management. 1993;17-67 Churchill Livingstone, New York.
26. Kawabata A., Umeda N., Takagi H. L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-met-enkephalin pathway ana NO-cyclic GMP pathway. British Journal of Pharmacology. 109:1993;73-79.
27. Kim S.H., Na H.S., Sheen K., Chung J.M. Effects of sympathectomy on a rat model of peripheral neuropathy. Pain. 55:1993;85-92.
28. Kitto K.F., Haley J.E., Wilcox G.L. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neuroscience Letters. 148:1992;1-5.
29. Kolesnikov Y., Jain S., Pasternak G.W. Modulation of opioid analgesia by agmatine. European Journal of Pharmacology. 296:1996;17-22.
30. Koltzenburg M., Wall P.D., McMahon S.B. Does the right side know what the left is doing? Trends Neuroscience. 22:1999;122-127.
31. Lee Chin J.R. Determination of the catecholamines and serotonin, their precursors tyrosine and their main metabolites in rat brain using reversed-phase high performance liquid chromatography with fluorimetric and oxidative amperometric detection in series. Journal of Chromatography. 578:1992;17-30.
32. Levy D., Zochodne D.W. Local nitric oxide synthase activity in a model of neuropathic pain. European Journal of Neuroscience. 10:1998;1846-1855.
33. Li G., Regunathan S., Barrow C.S., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 263:1994;966-969.
34. Li J., Li X., Pei G., Qin B.Y. Analgesic effect of agmatine and its enhancement on morphine analgesia in mice and rats. Acta Pharmacology Sinica. 20:1999;81-85.
35. Lou D., Knezevich S., Vincent S.R. N-methyl-D-aspartate-induced nitric oxide release. An in vivo microdialysis study. Neuroscience. 57:1993;897-900.
36. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain. 54:1993;291-300.
37. Mao J., Price D.D., Hayes R.L., Lu J., Mayer D.J. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Research. 598:1992;271-278.
38. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK 801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Research. 576:1992;254-262.
39. Maqbool A., Batten T.F.C., Mac William P.N. Co-localization of neurotransmitter immunoreactivities in putative nitric oxide synthesizing neurones of the cat brain stem. Journal of Chemical Neuroanatomy. 8:1995;191-206.
40. Meller S.T., Pechman P.S., Gebhart G.F., Maves T.J. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience. 50:1992;7-10.
41. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
42. Moncada S., Palmer M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews. 43:1991;109-142.
43. Moncada S., Higgs A. The L-Arginine-nitric oxide pathway. The New England Journal of Medicine. 329:1993;2002-2012.
44. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. British Journal of Pharmacology. 102:1991;198-202.
45. Nicdbala B., Sanchez A., Feria M. Nitric oxide mediates neuropathic pain behavior in peripherally denervated rats. Neuroscience Letters. 188:1995;57-60.
46. Ossipov M.H., Malan T.P. Jr., Lai J., Porreca F. Opioid pharmacology of acute and chronic pain. Dickenson A., Besson J.M. The Pharmacology of Pain. 1997;305-333 Springer-Verlag, Berlin Heidelberg.
47. Otake K., Ruggiero D.A., Regunathan S., Wang H., Milner T.A., Reis D.J. Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Research. 787:1998;1-14.
48. Önal A., Soykan N. Agmatine produces antinociception in tonic pain in mice. Pharmacology Biochemistry and Behavior. 69:2001;93-94.
49. Parsons C.G. NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol. 429:2001;71-78.
50. Piletz J.E., Chikkala D.N., Ernsberger P. Comparison of the properties of agmatine ana endogenous clonidine-displacing substance at imidazoline and α-2 adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 272:1995;581-587.
51. Pinthong D., Wright I.K., Hanmer C., Millns P., Mason R., Kendall D.A., Wilson V.G. Agmatine recognizes alpha-2 adrenoceptor binding sites but neither activates nor inhibits alpha-2 adrenoceptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 351:1995;10-16.
52. Raasch W., Regunathan S., Li G., Reis D.J. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Science. 56:1995;2319-2330.
53. Radhakrishnan V., Henry J.L. L-NAME blocks responses to NMDA, substance P and noxious cutaneous stimuli in cat dorsal horn. NeuroReport. 4:1993;323-326.
54. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Archives International Pharmacodynamics and Therapeutics. 111:1957;409-418.
55. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain? TİPS. 21:2000;187-193.
56. Roberts W.S. A hypothesis on the physiological basis for causalgia and related pains. Pain. 24:1986;297-311.
57. Rodrigo J., Springall D.R., Uttenthal O., Bentura M.L., Abadia-Molina F., Riveros-Moreno V., Martinez-Murillo R., Polak J.M., Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 341:1994;175-221.
58. Salter M., Strijbos P.J., Neale S., Duffy C., Follenfant R.L., Garthwaite J. The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neuroscience. 73:1996;649-655.
59. Scherzer C.R., Landwehrmeyer G.B., Kerner J.A., Standaert D.G., Hollingsworth Z.R., Daggett L.P., Veliçelebi G., Penney J.B., Young A.B. Cellular distribution of NMDA glutamate receptor subunit mRNAs inthe human cerbellum. Neurobiology of Disease. 4:1997;35-46.
60. Seltzer Z., Beilin B.Z., Ginzburg R., Paran Y., Shimko T. The role of injury discharge in the induction of neuropathic pain behavior in rats. Pain. 46:1991;327-336.
61. Shir Y., Seltzer Z. Effects of sympathectomy in a model of causalgiform pain produced by partial sciatic nerve injury in rats. Pain. 45:1991;309-320.
62. Shir Y., Cameron L.B., Srinivasa N.J., Bourke D.L. The safety of intravenous phentolamine administration in patients with neuropathic pain. Anesthesia and Analgesia. 76:1993;1008-1111.
63. Small J.R., Scadding J.W., Landon D.N. A fluorescence study of changes in noradrenergic sympathetic fibres in experimental peripheral nerve neuromas. Journal of the Neurological Science. 100:1990;98-107.
64. Smith G.D., Wiseman J., Harrison S.M., Elliot P.J., Birch P.J. Pretreatment with MK-801, a non-competitive NMDA antagonist prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation. Neuroscience Letter. 165:1994;79-83.
65. Steel J.H., Terenghi G., Chung J.M., Na H.S., Carlton S.M., Polak J.M. Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neuroscience Letters. 169:1994;81-84.
66. Tal M., Bennett G.J. Mechano-hyperalgesia and allodynia in the territory of the injured nerve and an adjacent normal nerve in a rat model of a peripheral neuropathy. Pain. 57:1994;375-382.
67. Taşkiran D., Kutay F.Z., Sözmen E., Pogun S. Sex differences in nitrite/nitrate levels and antioxidant defense in rat brain. NeuroReport. 8:1997;881-884.
68. Thomas D.A., Ren K., Besse D., Ruda M.A., Dubner R. Application of nitric oxide synthase inhibitor, N omega-nitro-L-arginine methyl ester, on injured nerve attenuates neuropathy-induced thermal hyperalgesia in rats. Neuroscience Letter. 210:1996;124-126.
69. Wong C.S., Cherng C.H., Tung C.S. Intrathecal administration of excitatory amino acid antagonists or nitric oxide synthase inhibitor reduced autotomy behavior in rats. Anesthesia and Analgesia. 87:1998;605-608.
70. Xu X.-J., Wiesenfeld-Hallin Z. Novel Modulators in Nociception. Dickenson A., Besson J.M. The Pharmacology of Pain. 1997;305-333 Springer-Verlag, Berlin Heidelberg.
71. Yaksh T.L., Pogrel J.W., Lee Y.W., Chaplan S.R. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonist. The Journal of Pharmacology and Experimental Therapeutics. 272:1995;207-214.
72. Yang X.C., Reis D.J. Agmatine selectively blocks the NMDA subclass of glutamate receptor channels in cultured mouse hippocampal neurons. The Journal of Pharmacolgy and Experimental Therapeutics. 288:1999;544-549.
73. 2-adrenoceptor-mediated mechanism in mice. Neuropharmacol. 25:2001;99-103.
74. Yoon Y.W., Sung B., Chung J.M. Nitric oxide mediates behavioral signs of neuropathic pain in an experimental rat model. NeuroReport. 9:1998;367-372.
75. Yu C.G., Marcillo A.E., Fairbanks C.A., Wilcox G.L., Yezierski R.P. Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. NeuroReport. 11:2000;3203-3207.